Diagnosis and treatment of female sexual dysfunction

American Family Physician

Volumn 77, Issue 5, 2008, Pages 635-642

  Frank, Jennifer E ^a,d   Mistretta, Patricia ^b   Will, Joshua ^c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b MARTIN ARMY COMMUNITY HOSPITAL   (United States)

^c EVANS ARMY COMMUNITY HOSPITAL   (United States)

^d University of Wisconsin   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; DOPAMINE; ESTROGEN; MIRTAZAPINE; NITRIC OXIDE; NORADRENALIN; OXYTOCIN; PHOSPHODIESTERASE INHIBITOR; PROGESTERONE; PROLACTIN; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; TESTOSTERONE; TOPICAL AGENT; TRICYCLIC ANTIDEPRESSANT AGENT; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANAMNESIS; ANORGASMIA; ARTICLE; CHECKLIST; COGNITIVE THERAPY; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC VALUE; DRUG EFFICACY; DRUG SAFETY; DYSPAREUNIA; ERECTILE DYSFUNCTION; FEMALE; FEMALE SEXUAL DYSFUNCTION; HORMONAL THERAPY; HUMAN; HYPOACTIVE SEXUAL DESIRE DISORDER; INTIMACY; LABORATORY TEST; LIBIDO DISORDER; MARITAL THERAPY; MENOPAUSAL SYNDROME; ORGASM DISORDER; PATHOPHYSIOLOGY; PATIENT EDUCATION; PELVIC FLOOR MUSCLE TRAINING; PHYSICAL EXAMINATION; PHYSICIAN ATTITUDE; PHYSIOTHERAPY; PREVALENCE; PSYCHOTHERAPY; SEXUAL AROUSAL DISORDER; SEXUAL AVERSION DISORDER; SEXUAL BEHAVIOR; SEXUAL FUNCTION; SEXUAL SATISFACTION; THERAPY DELAY; TREATMENT OUTCOME; URINE INCONTINENCE; VAGINA ATROPHY; VAGINA CANDIDIASIS; VAGINAL DRYNESS; VAGINISM; VULVAR VESTIBULITIS;

DIAGNOSIS, DIFFERENTIAL; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; PRACTICE GUIDELINES AS TOPIC; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; TREATMENT OUTCOME;

EID: 40549110994     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Basson R. Women's sexual dysfunction: revised and expanded definitions. CMAJ. 2005;172(10):1327-1333.
2. Clayton AH. Sexual function and dysfunction in women. Psychiatr Clin North Am. 2003;26(3):673-682.
3. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States. JAMA. 1999;281(6):537-544.
4. Nicolosi A, Laumann EO, Glasser DB, Moreira ED, Paik A, Gingell C. Sexual behavior and sexual dysfunctions after age 40: the global study of sexual attitudes and behaviors. Urology. 2004;64(5):991-997.
5. Lewis RW, Fugl-Meyer KS, Bosch R, et al. Epidemiology/risk factors of sexual dysfunction. J Sex Med. 2004; 1(1):35-39.
6. Simons JS, Carey MP. Prevalence of sexual dysfunctions: results from a decade of research. Arch Sex Behav. 2001;30(2):177-219.
7. Sexual and gender identity disorders. In: American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 2000:493-538.
8. Basson R, Althof S, Davis S, et al. Summary of the recommendations on sexual dysfunctions in women. J Sex Med. 2004;1(1):24-34.
9. Crowley T, Richardson D, Goldmeier D. Recommendations for the management of vaginismus: BASHH Special Interest Group for Sexual Dysfunction. Int J STD AIDS. 2006;17(1):14-18.
10. Moynihan R. The making of a disease: female sexual dysfunction. BMJ. 2003;326(7379):45-47.
11. Berman JR. Physiology of female sexual function and dysfunction. Int J Impot Res. 2005;(17 suppl 1):S44-S51.
12. Davis SR, Davison SL, Donath S, Bell RJ. Circulating androgen levels and self-reported sexual function in women. JAMA. 2005;294(1):91-96.
13. Potter JE. A 60-year-old woman with sexual difficulties. JAMA. 2007;297(6):620-633.
14. Bachmann G. Female sexuality and sexual dysfunction: are we stuck on the learning curve? J Sex Med. 2006;3(4):639-645.
15. Feldman J, Striepe M. Women's sexual health. Clin Fam Pract. 2004;6(4):839-861.
16. Nusbaum MRH, Hamilton CD. The proactive sexual health history. Am Fam Physician. 2002;66(9):1705-1712.
17. Meston CM, Derogatis LR. Validated instruments for assessing female sexual function. J Sex Marital Ther. 2002;(28 suppl 1):155-164.
18. Hatzichristou D, Rosen RC, Broderick G, et al. Clinical evaluation and management strategy for sexual dysfunction in men and women. J Sex Med. 2004;1(1):49-57.
19. Ragucci KR, Culhane NS. Treatment of female sexual dysfunction. Ann Pharmacother. 2003;37(4):546-555.
20. Dennerstein L, Randolph J, Taffe J, Dudley E, Burger H. Hormones, mood, sexuality, and the menopausal transition. Fertil Steril. 2002;(77 suppl 4):S42-S48.
21. Baldwin D, Mayers A. Sexual side-effects of antidepressant and antipsychotic drugs. Adv Psychiatr Treat. 2003;9:202-210.
22. Werneke U, Northey S, Bhugra D. Antidepressants and sexual dysfunction. Acta Psychiatr Scand. 2006; 114(6):384-397.
23. Balon R. SSRI-associated sexual dysfunction. Am J Psychiatry. 2006;163(9):1504-1509.
24. Weijmar Schultz W, Basson R, Binik Y, et al. Women's sexual pain and its management. J Sex Med. 2005; 2(3):301-316.
25. Shifren JL, Braunstein GD, Simon JA, et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med. 2000;343(10):682-688.
26. Braunstein GD, Sundwall DA, Katz M, et al. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. Arch Intern Med. 2005;165(14):1582-1589.
27. Simon J, Braunstein G, Nachtigall L, et al. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab. 2005;90(9):5226-5233.
28. Davis SR, van der Mooren MJ, van Lunsen RHW, et al. Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. Menopause. 2006;13(3):387-396.
29. Buster JE, Kingsberg SA, Aguirre O, et al. Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial. Obstet Gynecol. 2005;105(5 pt 1):944-952.
30. Basson R. Sexual desire and arousal disorders in women. N Engl J Med. 2006;354(14):1497-1506.
31. Berman JR, Berman LA, Toler SM, Gill J, Haughie S. Safety and efficacy of sildenafil citrate for the treatment of female sexual arousal disorder: a double blind, placebo controlled study. J Urol. 2003;170(6 pt 1):2333-2338.
32. Segraves RT, Clayton A, Croft H, Wolf A, Warnock J. Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women. J Clin Psychopharmacol. 2004;24(3):339-342.
33. Billups KL, Berman L, Berman J, Metz ME, Glennon ME, Goldstein I. A new non-pharmacological vacuum therapy for female sexual dysfunction. J Sex Marital Ther. 2001;27(5):435-441.
34. Wilson SK, Delk JR II, Billups KL. Treating symptoms of female sexual arousal disorder with the Eros-Clitoral Therapy Device. J Gend Specif Med. 2001;4(2):54-58.
35. Meston CM, Hull E, Levin RJ, Sipski M. Disorders of orgasm in women. J Sex Med. 2004;1(1):66-68.
36. Modell JG, May RS, Kathou CR. Effect of bupropion SR on orgasmic dysfunction in nondepressed subjects: a pilot study. J Sex Marital Ther. 2000;26(3):231-240.
37. Rosenbaum TY. Physiotherapy treatment of sexual pain disorders. J Sex Marital Ther. 2005;31(4):329-340.
38. Ter Kuile MM, Weijenborg PTM. A cognitive-behavioral group program for women with vulvar vestibulitis syndrome (VVS): factors associated with treatment success. J Sex Marital Ther. 2006;32(3):199-213.
39. McGuire H, Hawton K. Interventions for vaginismus. Cochrane Database Syst Rev. 2003;(1):CD001760.